Phase 1 study of narnatumab, an anti-RON receptor monoclonal antibody, in patients with advanced solid tumors

Patricia LoRusso, Mrinal M. Gounder, Shadia I. Jalal, Valérie André, Siva Rama Prasad Kambhampati, Nick Loizos, Jennifer Hall, Timothy R. Holzer, Aejaz Nasir, Jan Cosaert,

Investigational New Drugs · 2017 · 22 citations · 19 references

DOIFull text

Open access

Concepts

References

19